Literature DB >> 24828241

Paradoxical effects of antioxidants on cancer.

Andrew R Mendelsohn1, James W Larrick.   

Abstract

Antioxidants have had a checkered history concerning their reported ability to prevent or treat cancer. Early studies that showed ascorbate had benefit in cancer were followed by more definitive studies that demonstrated no benefit. Recent work suggests that biological context may be key to predicting whether antioxidants impede or even promote tumorigenesis. In a recent report, the antioxidants N-acetylcysteine and vitamin E accelerated tumorigenesis of lung cancer in mice. antioxidants decrease reactive oxygen species (ROS) levels, which paradoxically increase the proliferation rate of lung cancer cells, resulting in greater tumor burdens and reduced survival. Increased proliferation rates result from decreased expression of the genomic watchdog protein p53. In mice lacking p53, neither anti-oxidant affects tumor growth. But antioxidants can be used to kill cancer, at least in rodents. High concentrations of the "antioxidant" ascorbate, achievable only by injection in vivo, result in the production of ascorbate radicals and hydrogen peroxide in the extracellular fluid that kills cancer cells, but not normal cells. In preliminary human trials, ascorbate reduced the toxicity of chemotherapy, but showed no statistical benefit on disease progression. Vitamin C is beneficial when it acts as an oxidant. These studies are consistent with others that suggest that even tumor suppressor genes, such as Nrf2, which stimulate innate cellular stress protection pathways that reduce ROS, can promote cancer progression. Nrf2 is required for the cancer preventive effects of compounds such as sulforaphane, but Nrf2 can help maintain an aggressive tumor phenotype by stimulating proliferation and offering protection from chemotherapy. Context determines whether a specific gene is a tumor enhancer or a suppressor. Such paradoxical behavior creates difficult problems for the development of conventional therapeutics to fight cancer. Personal genomic analysis may provide the means to identify context to avoid these paradoxes and obtain a successful outcome. However, cancer prevention may be more difficult than previously thought.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24828241     DOI: 10.1089/rej.2014.1577

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  10 in total

1.  Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia.

Authors:  Delphine Casabonne; Esther Gracia; Ana Espinosa; Mariona Bustamante; Yolanda Benavente; Claudia Robles; Laura Costas; Esther Alonso; Eva Gonzalez-Barca; Adonina Tardón; Trinidad Dierssen-Sotos; Eva Gimeno Vázquez; Marta Aymerich; Elies Campo; José J Jiménez-Moleón; Rafael Marcos-Gragera; Gemma Castaño-Vinyals; Nuria Aragones; Marina Pollan; Manolis Kogevinas; Carmen Urtiaga; Pilar Amiano; Victor Moreno; Silvia de Sanjose
Journal:  Eur J Nutr       Date:  2016-02-02       Impact factor: 5.614

2.  New considerations on hormetic response against oxidative stress.

Authors:  Armando Luna-López; Viridiana Y González-Puertos; Norma E López-Diazguerrero; Mina Königsberg
Journal:  J Cell Commun Signal       Date:  2014-10-05       Impact factor: 5.782

3.  Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.

Authors:  Edward Sanders; Svenja Diehl
Journal:  Oncoscience       Date:  2015-02-17

Review 4.  Antioxidative properties of phenolic compounds and their effect on oxidative stress induced by severe physical exercise.

Authors:  Joanna Kruk; Basil Hassan Aboul-Enein; Ewa Duchnik; Mariola Marchlewicz
Journal:  J Physiol Sci       Date:  2022-08-05       Impact factor: 2.257

5.  Anti-Inflammatory and Antioxidant Effects of the Indole-Derived N-Salicyloyltryptamine on Peritonitis and Joint Disability Induced by Carrageenan in Rodents.

Authors:  B P Sousa-Neto; F V M Cunha; Daniel Barbosa Nunes; B S Gomes; Layane Valeria Amorim; Everton Moraes Lopes; S J C Gutierrez; F R C Almeida; D D R Arcanjo; M F V Souza; F A Oliveira
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-13       Impact factor: 2.650

6.  Alterations in Sod2-Induced Oxidative Stress Affect Endocrine Cancer Progression.

Authors:  Amruta Ashtekar; Danielle Huk; Alexa Magner; Krista M D La Perle; Laura Boucai; Lawrence S Kirschner
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

7.  Chemoprotective effect of atorvastatin against benzo(a)pyrene-induced lung cancer via the inhibition of oxidative stress and inflammatory parameters.

Authors:  Xusheng Du; Dongfan Li; Guanjie Wang; Yali Fan; Namiao Li; Lili Chai; Guangshun Li; Jianying Li
Journal:  Ann Transl Med       Date:  2021-02

Review 8.  DNA mismatch repair and oxidative DNA damage: implications for cancer biology and treatment.

Authors:  Gemma Bridge; Sukaina Rashid; Sarah A Martin
Journal:  Cancers (Basel)       Date:  2014-08-05       Impact factor: 6.639

Review 9.  Reductive Stress in Inflammation-Associated Diseases and the Pro-Oxidant Effect of Antioxidant Agents.

Authors:  Israel Pérez-Torres; Verónica Guarner-Lans; María Esther Rubio-Ruiz
Journal:  Int J Mol Sci       Date:  2017-10-05       Impact factor: 5.923

Review 10.  Usefulness of Melatonin and Other Compounds as Antioxidants and Epidrugs in the Treatment of Head and Neck Cancer.

Authors:  Joaquín Guerra; Jesús Devesa
Journal:  Antioxidants (Basel)       Date:  2021-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.